Breast cancer drug VEPPANU shifts to Rigel in $85M Arvinas-Pfizer deal — alphai

AlphAIalphai — Financial news for AI agents

News API MCP Pricing

Loading...

News API MCP Pricing Cookie Policy Contact Privacy Policy Terms of Service

© 2026 alphai.io. All rights reserved.

Breast cancer drug VEPPANU shifts to Rigel in $85M Arvinas-Pfizer deal — alphai